- 3.4Impact Factor
- 9.9CiteScore
- 20 daysTime to First Decision
Vaccines, Volume 13, Issue 4
April 2025 - 98 articles
Cover Story: This review provides a comprehensive overview of adenoviral (Ad) vector-based COVID-19 vaccines, exploring their biology, structure, immune responses, and clinical applications. It highlights the advantages of Ad vectors, such as strong immunity and scalable production, while addressing challenges like preexisting vector immunity and reduced efficacy against emerging variants. The review sheds light on innovative strategies, including vector redesign, alternative delivery methods, and multivalent approaches to enhance immune coverage and durability. It also emphasizes the need for next-generation Ad vaccines to ensure global preparedness against emerging SARS-CoV-2 variants. View this paper
- Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
- You may sign up for email alerts to receive table of contents of newly released issues.
- PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Articles
There are no articles in this issue yet.
Get Alerted
Add your email address to receive forthcoming issues of this journal.
Vaccines - ISSN 2076-393XCreative Common CC BY license